FAST NEWS: New Injectable Drug from Simcere Pharma Approved For Marketing In China
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced Wednesday it will market Cosela, a cyclin-dependent kinase CDK4/6 inhibitor developed by the group with G1 Therapeutics, in China after receiving conditional approval from the…
FAST NEWS: Innocare Pharma Loss Narrows on New Drug’s Contribution
The latest: Drug maker InnoCare Pharma Ltd. (9969.HK) announced Wednesday that its net loss shrank by 83.5% to 64.5 million yuan ($10.1 million) last year from 2020 levels. Looking up: The company…
FAST NEWS: MicroPort Scientific’s Shanghai Unit Posted Up to 50% Profit Growth Last Year
The latest: Medical device maker MicroPort Scientific Corp. (0853.HK) said late on Monday that its 46%-owned subsidiary, Shanghai MicroPort Endovascular MedTech (Group) Co. Ltd. (688016.CN), will record a 40% to…
RECENT ARTICLES
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK 42.70 (-1.4%) - Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK 6.62 (+2.2%)
- As Covid drug cash dwindles, Vigonvita targets new remedies
